Matches in Nanopublications for { ?s ?p ""Coadministration with stavudine allopurinol or ribavirin is contraindicated. ( 4 VIDEX EC is contraindicated when coadministered with the following medications: Stavudine- potential for serious and/or life-threatening events, notably pancreatitis, lactic acidosis, hepatotoxicity, and peripheral neuropathy [ see Warnings and Precautions 5.1 5.2 5.3 5.5 Allopurinol- systemic exposures of didanosine are increased, which may increase didanosine-associated toxicity [ see Clinical Pharmacology (12.3) Ribavirin- exposures of the active metabolite of didanosine (dideoxyadenosine 5'-triphosphate) are increased. Fatal hepatic failure, as well as peripheral neuropathy, pancreatitis, and symptomatic hyperlactatemia/lactic acidosis have been reported in patients receiving both didanosine and ribavirin."" ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- association label ""Coadministration with stavudine allopurinol or ribavirin is contraindicated. ( 4 VIDEX EC is contraindicated when coadministered with the following medications: Stavudine- potential for serious and/or life-threatening events, notably pancreatitis, lactic acidosis, hepatotoxicity, and peripheral neuropathy [ see Warnings and Precautions 5.1 5.2 5.3 5.5 Allopurinol- systemic exposures of didanosine are increased, which may increase didanosine-associated toxicity [ see Clinical Pharmacology (12.3) Ribavirin- exposures of the active metabolite of didanosine (dideoxyadenosine 5'-triphosphate) are increased. Fatal hepatic failure, as well as peripheral neuropathy, pancreatitis, and symptomatic hyperlactatemia/lactic acidosis have been reported in patients receiving both didanosine and ribavirin."" assertion.